Wow. Didn’t think we’d need the depth this quickly.
Let’s break down the injuries 🙄 and everything else that’s going on this Spring.
Frazier has an oblique strain that “doesn’t appear to be severe,” but he’s being flown to New York to receive a cortisone shot, and there’s no timetable for his return.
First. We don’t have any cortisone in Florida? Ok, maybe we are just erring on the side of caution, but we are now. without two third baseman who figured to play major roles on this team.
If it was up to me, Jeff McNeil would be the third baseman. Mickey Callaway shot down that idea right away, saying there are no plans to move McNeil from the outfield at this point. Well, I guess it’s on you JD Davis. Again, the injuries to Frazier and Lowrie are “not severe” according to Mets officials, but I’ve heard that before.
Hey, the injuries did give David Thompson a chance to make a name for himself yesterday. The 2015 draft pick smacked a three run homerun through the wind against the Astros yesterday.
Here’s some good news. Brandon Nimmo, who had been experiencing shoulder soreness, served as DH today against the Detroit Tigers. He went 1-5 with a well struck single.
Still no signs of d’Arnaud in early Grapefruit League play, but Mickey Callaway says he is healthy. D’Arnaud is spending his time on the backfields, going through simulations, getting ready.
Why do I get the feeling we are going to see a lot of Devin Mesoraco this year?
Eiland has some lofty goals for his starting pitchers going forward. He offered this quote when asked about Jacob deGrom’s Cy Young award.
“Those personal awards are well and good, and Jake most certainly is deserving and all that,” Eiland said. “But what I want to see from each of these guys, our first four starters. I want to see all of them get a win in the World Series.”
Me too, Dave. 👌
Syndergaard was impressive in his Spring Training debut, only needing 23 pitches to get through 2 innings of work.
Syndergaard sat at 98 MPH, topping out at 99.
AROUND THE LEAGUE
According to Jeff Passan of ESPN, Nolan Arenado and the Colorado Rockies are finalizing an eight-year deal with an opt-out after three seasons that is worth more than $255 million.